Overview
Modulates GABA-A receptors to increase inhibitory action on neuronal excitability.
Proposed mechanism
Modulates GABA-A receptor expression, enhances brain-derived neurotrophic factor (BDNF) expression, and regulates enkephalin degradation, producing anxiolytic and cognitive-enhancing effects.
What the evidence supports
Human data exists but the trials are small, short-term, or not yet replicated.
Graded Human-limited
Human data that exists but is thin: open-label work, single-arm studies, small cohorts, or observational follow-up without randomisation.
Key citations
Representative primary sources, including results that did not favour the compound.
- [1]
Selank in anxiety disorders
· DOI:10.17116/jnevro201611651123-131 · 2016
- [2]
Tuftsin analogs and anxiety
· DOI:10.1007/s11055-015-0055-1 · 2015
- [3]
Semenova et al. — Selank and anxiety in humans
· · 0
- [4]
Zozulya et al. — Selank as a stable tuftsin analogue
· · 0
Citation records in this build are illustrative placeholders for the design.
Reference information for research purposes. Not medical advice, and not a recommendation to use any compound. Many entries describe substances that are not approved for human use.